BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1963 related articles for article (PubMed ID: 32470749)

  • 1. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders.
    Furlotti G; Alisi MA; Cazzolla N; Dragone P; Durando L; Magarò G; Mancini F; Mangano G; Ombrato R; Vitiello M; Armirotti A; Capurro V; Lanfranco M; Ottonello G; Summa M; Reggiani A
    J Med Chem; 2015 Nov; 58(22):8920-37. PubMed ID: 26486317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of small molecules that inhibit GSK-3beta through virtual screening.
    Kang NS; Lee GN; Kim CH; Bae MA; Kim I; Cho YS
    Bioorg Med Chem Lett; 2009 Jan; 19(2):533-7. PubMed ID: 19081248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Novel Imidazopyridine GSK-3β Inhibitors Supported by Computational Approaches.
    Buonfiglio R; Prati F; Bischetti M; Cavarischia C; Furlotti G; Ombrato R
    Molecules; 2020 May; 25(9):. PubMed ID: 32380735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel selective and potent inhibitor of glycogen synthase kinase-3.
    Noori MS; Bhatt PM; Courreges MC; Ghazanfari D; Cuckler C; Orac CM; McMills MC; Schwartz FL; Deosarkar SP; Bergmeier SC; McCall KD; Goetz DJ
    Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1289-C1303. PubMed ID: 31553649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery of novel benzothiazinones as highly selective non-ATP competitive glycogen synthase kinase 3β inhibitors for the treatment of ovarian cancer.
    Gao Y; Ye DY; Zhou WC; Chu Y
    Eur J Med Chem; 2017 Jul; 135():370-381. PubMed ID: 28460311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Discovery of 1H-Indazole-3-carboxamides as a Novel Structural Class of Human GSK-3 Inhibitors.
    Ombrato R; Cazzolla N; Mancini F; Mangano G
    J Chem Inf Model; 2015 Dec; 55(12):2540-51. PubMed ID: 26600430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
    Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice.
    Uno Y; Iwashita H; Tsukamoto T; Uchiyama N; Kawamoto T; Kori M; Nakanishi A
    Brain Res; 2009 Nov; 1296():148-63. PubMed ID: 19698704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
    Zhang P; Hu HR; Huang ZH; Lei JY; Chu Y; Ye DY
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7232-6. PubMed ID: 23099099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a glycogen synthase kinase-3β inhibitor that attenuates hyperactivity in CLOCK mutant mice.
    Kozikowski AP; Gunosewoyo H; Guo S; Gaisina IN; Walter RL; Ketcherside A; McClung CA; Mesecar AD; Caldarone B
    ChemMedChem; 2011 Sep; 6(9):1593-602. PubMed ID: 21732538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of glycogen synthase kinase 3 beta in multiple sclerosis.
    Noori T; Dehpour AR; Sureda A; Fakhri S; Sobarzo-Sanchez E; Farzaei MH; Küpeli Akkol E; Khodarahmi Z; Hosseini SZ; Alavi SD; Shirooie S
    Biomed Pharmacother; 2020 Dec; 132():110874. PubMed ID: 33080467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha.
    Kirshenboim N; Plotkin B; Shlomo SB; Kaidanovich-Beilin O; Eldar-Finkelman H
    J Mol Neurosci; 2004; 24(2):237-45. PubMed ID: 15456937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.
    Kozikowski AP; Gaisina IN; Yuan H; Petukhov PA; Blond SY; Fedolak A; Caldarone B; McGonigle P
    J Am Chem Soc; 2007 Jul; 129(26):8328-32. PubMed ID: 17552518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
    Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
    Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3beta in N1E-115 neuroblastoma cells.
    Ishii T; Furuoka H; Muroi Y; Nishimura M
    J Biol Chem; 2003 Jul; 278(29):26970-5. PubMed ID: 12714590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling pathways mediating phosphorylation and inactivation of glycogen synthase kinase-3β by the recombinant human δ-opioid receptor stably expressed in Chinese hamster ovary cells.
    Olianas MC; Dedoni S; Onali P
    Neuropharmacology; 2011 Jun; 60(7-8):1326-36. PubMed ID: 21276805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase 3: an emerging therapeutic target.
    Eldar-Finkelman H
    Trends Mol Med; 2002 Mar; 8(3):126-32. PubMed ID: 11879773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3β).
    Lohning A; Kidachi Y; Kamiie K; Sasaki K; Ryoyama K; Yamaguchi H
    Eur J Med Chem; 2021 Apr; 216():113250. PubMed ID: 33691258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 99.